Rocket Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
51.54
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
12
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.79
|
-0.87
|
-0.08
|
-10.13%
|
|
2022-06-30
|
-0.68
|
-0.83
|
-0.15
|
-22.06%
|
|
2022-03-31
|
-0.71
|
-0.67
|
0.04
|
5.63%
|
|
2021-12-31
|
-0.76
|
-0.69
|
0.07
|
9.21%
|
|
2021-09-30
|
-0.61
|
-0.79
|
-0.18
|
-29.51%
|
|
2021-06-30
|
-0.65
|
-0.55
|
0.10
|
15.38%
|
|
2021-03-31
|
-0.69
|
-0.65
|
0.04
|
5.80%
|
|
2020-12-31
|
-0.51
|
-1.08
|
-0.57
|
-111.76%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.37
|
|
2021-12-31
|
-2.68
|
|
2020-12-31
|
-2.51
|
|
2019-12-31
|
-1.58
|
|
2018-12-31
|
-1.88
|
|
2017-12-31
|
-3.55
|
|
2016-12-31
|
-6.40
|
|
2015-12-31
|
-3.36
|
|
2014-12-31
|
-3.22
|